|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality and Re-Infarction in Consecutive Patients With Suspected Acute Coronary Syndrome Who Are Troponin-Negative显示文摘 | Karthik Viswanathan Niamh Kilcullen Christine Morrell Sue J. Thistlethwaite Mohan U. Sivananthan Tajek B. Hassan Julian H. Barth Alistair S. Hall | 2010 | Journal of the American College of Cardiology2010，，23： | 2 |
| 2 | Positive association in the absence of linkage suggests a minor role for the glucokinase gene in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus amongst South Indians显示文摘 | M. I. McCarthy M. Hitchins G. A. Hitman P. Cassell K. Hawrami N. Morton V. Mohan A. Ramachandran C. Snehalatha M. Viswanathan | 1993 | Diabetologia1993，，7： | 2 |
| 3 | Long-term ingestion of cassava (tapioca) does not produce diabetes or pancreatitis in the rat model显示文摘 | Damal C. Mathangi Raj Deepa Viswanathan Mohan Meera Govindarajan Ambalavanan Namasivayam | 2000 | International Journal of Pancreatology2000，，3： | 1 |
| 4 | Polymorphisms in the Fatty Acid-Binding Protein 2 and Apolipoprotein C-III Genes Are Associated with the Metabolic Syndrome and Dyslipidemia in a South Indian Population显示文摘 | Jean-Marc Guettier Angeliki Georgopoulos Michael Y. Tsai Venkatesan Radha Subramaniam Shanthirani Raj Deepa Myron Gross Gundu Rao Viswanathan Mohan | 2005 | The Journal of Clinical Endocrinology & Metabolism2005，，3： | 1 |
| 5 | A novel association of a polymorphism in the first intron of adiponectin gene with type 2 diabetes, obesity and hypoadiponectinemia in Asian Indians显示文摘 | Karani S. Vimaleswaran Venkatesan Radha Kandaswamy Ramya Hunsur Narayan Sathish Babu Nageshappa Savitha Venkataramaiah Roopa Dhar Monalisa Raj Deepa Saurabh Ghosh Partha P. Majumder M. R. Sathyanarayana Rao Viswanathan Mohan | 2008 | Human Genetics2008，，6： | 1 |
| 6 | Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes显示文摘 | Sandhya Narasimhan Kuppan Gokulakrishnan Rangasamy Sampathkumar Syed Farooq Radhakrishnan Ravikumar Viswanathan Mohan Muthuswamy Balasubramanyam | 2010 | Clinical Biochemistry2010，，10： | 1 |
| 7 | Hyperinsulinemia-induced vascular smooth muscle cell (VSMC) migration and proliferation is mediated by converging mechanisms of mitochondrial dysfunction and oxidative stress显示文摘 | Shiny Abhijit Regin Bhaskaran Abirami Narayanasamy Anand Chakroborty Nagaraj Manickam Madhulika Dixit Viswanathan Mohan Muthuswamy Balasubramanyam | 2013 | Molecular and Cellular Biochemistry2013，，1： | 1 |
| 8 | Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias显示文摘 | Barry London Michael Michalec Haider Mehdi Xiaodong Zhu Laurie Kerchner Shamarendra Sanyal Prakash C. Viswanathan Arnold E. Pfahnl Lijuan L. Shang Mohan Madhusudanan Catherine J. Baty Stephen Lagana Ryan Aleong Rebecca Gutmann Michael J. Ackerman Dennis M | 2007 | Circulation2007，，20： | 1 |
| 9 | Clinical profile and outcome of infantile onset diabetes mellitus in southern India显示文摘 | Poovazhagi Varadarajan Thangavelu Sangaralingam Senthil Senniappan Suresh Jahnavi Venkatesan Radha Viswanathan Mohan | 2013 | Indian Pediatrics2013，，8： | 1 |
| 10 | Prevalence of diabetic complications in fibrocalculous pancreatic diabetic patients and type 2 diabetic patients显示文摘 | Karuna Kanta Barman Mahesh Padmanabhan Gopal Premalatha Raj Deepa Mohan Rema Viswanathan Mohan | 2004 | Journal of Diabetes and Its Complications2004，，5： | 1 |
| 11 | Histopathology and immunohistochemistry of pancreatic islets in fibrocalculous pancreatic diabetes显示文摘 | Meera Govindarajan Viswanathan Mohan Raj Deepa Sundararaman Ashok Capecomarin S. Pitchumoni | 2001 | Diabetes Research and Clinical Practice2001，，1： | 1 |
| 12 | Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review显示文摘BACKGROUND Cardiovascular outcome trials have demonstrated cardiovascular safety of glimepiride(a sulfonylureas) against dipeptidyl peptidase-4 inhibitor linagliptin.Gliclazide(another newer sulfonylureas) has shown similar glycemic efficacy and 50% decreased risk of hypoglycemia compared to glimepiride.AIM Considering the absence of cardiovascular outcome trials for gliclazide, we decided to conduct a systematic review of the literature to assess the cardiovascular(CV) safety by assessing the risk for major adverse CV events and hypoglycemia risk of gliclazide vs linagliptin in patients with type 2 diabetes(T2D).METHODS This systematic review followed the current Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to analyze all the clinical studies published from 2008 that compared the two drugs in patients with T2D with no risk of CV disease(CVD). We included only evidence designated high quality by the Oxford Center for Evidence-based Medicine-Levels of Evidence.RESULTS Eight clinical studies were included in the narrative descriptive analysis(gliclazide: 5 and linagliptin: 3). The CV safety of gliclazide in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation trial and of linagliptin in the Cardiovascular and Renal Microvascular Outcome Study With Linagliptin(CARMELINA) and CARdiovascular Outcome study of LINAgliptin vs glimepiride in patients with T2D(CAROLINA)trials were excluded from the comparative analysis as these trials demonstrated CV and hypoglycemia benefits in patients at high risk of CVD. However, since these are landmark trials,they were discussed in brief to show the CV benefits and low hypoglycemia risk of gliclazide and linagliptin. We did not find any study comparing gliclazide with linagliptin. Hence, direct comparison of their major adverse CV events and hypoglycemia risk could not be carried out.However, the literature meeting the inclusion criteria showed that both drugs were effective in achieving the desired glycemic control and had low major adverse CV events and hypoglycemia risk in adult patients with no history of CVD.CONCLUSION Gliclazide can be considered an effective and safe glucose-lowering drug in T2D patients with no established CVD but at high risk of CVD due to their T2D status. Future randomized controlled trials comparing gliclazide with linagliptin or dipeptidyl peptidase-4 inhibitors can confirm these findings. | Viswanathan Mohan Subhash Wangnoo Sambit Das Rajnish Dhediya Kumar Gaurav | 2022 | World Journal of Diabetes2022，13，12： | 1 |
| 13 | Effect of spironolactone and amiloride on thiazolidinedione-induced fluid retention in South Indian patients with type 2 diabetes显示文摘 | Viswanathan V Mohan V Subramani P | 2013 | Clin J Am Soc Nephrol2013，8，2： | 1 |
| 14 | Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea显示文摘 | Viswanathan Mohan Wenying Yang Ho-Young Son Lei Xu Liliane Noble Ronald B. Langdon John M. Amatruda Peter P. Stein Keith D. Kaufman | 2008 | Diabetes Research and Clinical Practice2008，，1： | 1 |
| 15 | Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea显示文摘 | Yan Gao Kun Ho Yoon Lee-Ming Chuang Viswanathan Mohan Guang Ning Sanjiv Shah Hak Chul Jang Ta-Jen Wu Don Johns Justin Northrup Robert Brodows | 2008 | Diabetes Research and Clinical Practice2008，，1： | 1 |
| 16 | A1C Cut Points to Define Various Glucose Intolerance Groups in Asian Indians显示文摘 | Viswanathan Mohan Venkataraman Vijayachandrika Anbazhagan Ganesan | 2010 | Diabetes Care2010，33，3： | 1 |
| 17 | Current and Emerging Antiarrhythmic Drug Therapy for Ventricular Tachycardia显示文摘 | Eric S. Williams Mohan N. Viswanathan | 2013 | Cardiology and Therapy2013，，1： | 1 |
| 18 | Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea显示文摘 | Yan Gao Kun Ho Yoon Lee-Ming Chuang Viswanathan Mohan Guang Ning Sanjiv Shah Hak Chul Jang Ta-Jen Wu Don Johns Justin Northrup Robert Brodows | 2008 | Diabetes Research and Clinical Practice2008，，1： | 1 |
| 19 | Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset Type 1 and Type 2 Diabetes显示文摘 | Ramachandran Rajalakshmi Anandakumar Amutha Harish Ranjani Mohammed K. Ali Ranjit Unnikrishnan Ranjit Mohan Anjana K.M. Venkat Narayan Viswanathan Mohan | 2013 | Journal of Diabetes and Its Complications2013，，： | 1 |
| 20 | 预防和管理2型糖尿病的饮食和营养干预策略显示文摘Nita G Forouhi和同事们认为,我们可以找到预防、管理和可能缓解2型糖尿病的饮食方法基本要点。饮食因素在2型糖尿病的预防和管理中至关重要。尽管在制定循证饮食指南方面取得了进展,但争议和困惑依然存在。在本文中,我们研究了现有证据,确定2型糖尿病饮食指南中哪些领域取得了共识,哪些还存在不确定性或争议。 | Nita G Forouhi Anoop Misra Viswanathan Mohan Roy Taylor William Yancy 黄融(译) 竹萍(校) | 2019 | 英国医学杂志中文版2019，22，9： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员